Allurion Technologies Inc. (ALUR)
- Previous Close
2.3300 - Open
2.2600 - Bid --
- Ask --
- Day's Range
2.2700 - 2.5149 - 52 Week Range
2.1500 - 88.7500 - Volume
88,002 - Avg. Volume
1,509,820 - Market Cap (intraday)
14.193M - Beta (5Y Monthly) -0.62
- PE Ratio (TTM)
-- - EPS (TTM)
-11.6400 - Earnings Date May 14, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
10.62
Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform offers the Allurion Program, a swallowable and procedure-less intragastric balloon for weight loss, as well as provides access to artificial intelligence-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. The company operates in Spain, France, Turkey, and internationally. Allurion Technologies Inc. is headquartered in Natick, Massachusetts.
www.allurion.comRecent News: ALUR
View More
Performance Overview: ALUR
Trailing total returns as of 5/5/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ALUR
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ALUR
View MoreValuation Measures
Market Cap
14.19M
Enterprise Value
36.74M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.17
Price/Book (mrq)
--
Enterprise Value/Revenue
1.14
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-81.43%
Return on Assets (ttm)
-54.05%
Return on Equity (ttm)
--
Revenue (ttm)
32.11M
Net Income Avi to Common (ttm)
-26.15M
Diluted EPS (ttm)
-11.6400
Balance Sheet and Cash Flow
Total Cash (mrq)
15.38M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-16.8M